International Patent: USE OF ARIMOCLOMOL IN ACTIVATING CLEAR GENE EXPRESSION AS TREATMENT FOR LYSOSOMAL STORAGE DISORDERS

GENEVA, Oct. 22 -- ZEVRA THERAPEUTICS, INC. filed a patent application (US2025/035976) for “USE OF ARIMOCLOMOL IN ACTIVATING CLEAR GENE EXPRESSION AS TREATMENT FOR LYSOSOMAL STORAGE DISORDERS”. With publication no. WO/2026/010890, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 31/4545

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....